Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2026 Earnings Call Transcript
Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2026 Earnings Call Transcript May 14, 2026Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.33.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.10 | 454,545 | $499,999.50 | 944,956 | 2019-04-11 | Filing | |
| $1.45 | 140,000 | $203,378.00 | 140,000 | 2018-06-11 | Filing | |
| $2.09 | 591 | $1,234.19 | 167,491 | 2016-02-22 | Filing | |
| $2.08 | 1,700 | $3,529.03 | 166,900 | 2016-02-19 | Filing | |
| $2.09 | 4,500 | $9,400.95 | 165,200 | 2016-02-18 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,408 | $8,028 | 0% | |
| 2. | 950 | $810 | 0% | |
| 3. | 84 | $72 | 0% |